PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
30-Jan-2020 PharmaMar and Bionical Emas launch Expanded Access Program for lurbinectedin in relapsed Small Cell Lung Cancer in the U.S. PharmaMar and Bionical Emas
30-Jan-2020 Santhera Reports Net Revenues 2019 and Highlights Pipeline Progress Santhera Pharmaceuticals Holding AG
30-Jan-2020 Bionetix, ProQinase, and Mercachemsyncom Announce a Joint Research Project from Target Identification to Clinical Study Bionetix, ProQinase, and Mercachemsyncom
30-Jan-2020 Autolus' Chief Scientific Officer, Dr Martin Pulé, to give Keynote Lecture at the EHA-EBMT 2nd European CAR T Cell Meeting Autolus Therapeutics plc
30-Jan-2020 Cresset joins 3D-NEONET consortium to help accelerate the development of novel therapeutics in cancer and ophthalmology Cresset
29-Jan-2020 Most innovative cancer drugs facing delays in reaching patients The Institute of Cancer Research
29-Jan-2020 Autolus Announces Closing of Public Offering Autolus Therapeutics plc
29-Jan-2020 Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis Sanofi
29-Jan-2020 Kite, a Gilead Company, to present latest cell therapy research at the 2nd European CAR T Cell Meeting, Sitges, Spain Gilead
29-Jan-2020 Most innovative cancer drugs facing delays in reaching patients The Institute of Cancer Research
29-Jan-2020 HRA PHARMA TAKES OVER DISTRIBUTION IN AUSTRIA HRA Pharma
29-Jan-2020 Vein Illuminator Market Analysis & Technological Innovation by Leading Key Players Reports and Data
28-Jan-2020 Registration Opens for SMi’s 20th Annual Pain Therapeutics Conference SMi Group
28-Jan-2020 Pharmapack Europe unpacks key drivers and challenges in 2020 Pharmapack
28-Jan-2020 Clearvision, SoftComply and Comalatech launch compliance management solution MediCompli Clearvision
27-Jan-2020 Drug product formulation and control strategies discussed at PFS East Coast SMi Group
27-Jan-2020 Join experts within supply and demand at Europe’s Only Parallel Trade Conference 2020 in London SMi Group
24-Jan-2020 Dupixent®▼ (dupilumab), accepted for restricted use within NHS Wales for the treatment of moderate to severe atopic dermatitis in adolescents aged 12 years and over1 Sanofi
24-Jan-2020 Dupixent®▼ (dupilumab) available to treat adolescents with moderate to severe atopic dermatitis in Scotland1 Sanofi
24-Jan-2020 Sanofi Completes Acquisition of Synthorx, Inc. Sanofi